Clinical Trial Update: Evaluation of SC Injected Tc 99m Tilmanocept Localization in Active RA Subjects by SPECT and SPECT/CT Imaging [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating Tc-99m tilmanocept localization in active rheumatoid arthritis subjects using SPECT and SPECT/CT imaging; study completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Tilmanocept (Tilmanocept)

Snippet

Sponsor: Navidea Biopharmaceuticals | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED | Results posted: 2019-11-08